Internal Medicine, Medical Oncology · Vista, CA
NPI
1609879170
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2067 W Vista Way
Vista, CA, 92083
Phone (760) 298-5787
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
6,006 services
Medicare patients, 2024
89
Average age 72
Drug cost, 2024
$3.4M
926 prescriptions
Company payments, 2025
$3,801
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anwer A Shaikh was code 99214 (office e&m - established), 68 times for 37 patients. In total Anwer A Shaikh billed 6,006 services in 59 codes, and Medicare paid $83K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 68 | 37 | $91.28 | $6,207 |
| 99442 Telephone Services | Office | 47 | 18 | $50.94 | $2,394 |
| 96127 Behavioral Health Services | Office | 42 | 38 | $3.86 | $162 |
| 99213 Office E&M - Established | Office | 28 | 22 | $69.95 | $1,959 |
| 99204 Office E&M - New | Office | 21 | 21 | $121.17 | $2,545 |
By year: 2022 $204K for 8,202 services; 2023 $237K for 11,022 services; 2024 $83K for 6,006 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anwer A Shaikh prescribed most often to Medicare patients was Anastrozole, with 113 prescriptions and refills. In total Anwer A Shaikh wrote 926 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 113 | 281 | 38 | $1,600 |
| Alendronate Sodium Generic | 83 | 183 | 20 | $442 |
| Dexamethasone Generic | 68 | 80 | 11 | $953 |
| Letrozole Generic | 38 | 110 | 13 | $1,396 |
| Prednisone Generic | 32 | 55 | Under 11 | $89.03 |
| Lenalidomide Generic | 30 | 30 | Under 11 | $340K |
| Hydroxyurea Generic | 24 | 64 | Under 11 | $530 |
| Tamoxifen Citrate Generic | 23 | 63 | Under 11 | $792 |
| Revlimid Lenalidomide | 20 | 20 | Under 11 | $372K |
| Abiraterone Acetate Generic | 19 | 19 | Under 11 | $49K |
| Brukinsa Zanubrutinib | 19 | 19 | Under 11 | $280K |
| Diphenhydramine Hcl Generic | 18 | 18 | Under 11 | $46.19 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 18 | 18 | Under 11 | $593 |
| Bortezomib Generic | 17 | 17 | Under 11 | $40K |
| Orgovyx Relugolix | 17 | 17 | Under 11 | $45K |
Brand drugs: 230 claims; generic drugs: 696 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anwer A Shaikh $3,801 ($3,801 in general payments such as food, travel and fees) from 41 companies. The largest payer was Novartis Pharmaceuticals Corporation with $712.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 14 | $712 |
| Karyopharm Therapeutics Inc. KPTI | 7 | $289 |
| Incyte Corporation INCY | 10 | $227 |
| Janssen Biotech, Inc. JNJ | 8 | $197 |
| Pfizer Inc. PFE | 8 | $175 |
| Abbvie Inc. ABBV | 5 | $150 |
| Astellas Pharma US Inc 4503.T | 6 | $148 |
| Eisai Inc. 4523.T | 5 | $147 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $142 |
| Sanofi US Services Inc. SNY | 1 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.